Dr. Reddy's Labs Files 6-K Report
Ticker: RDY · Form: 6-K · Filed: Aug 8, 2025 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, regulatory
Related Tickers: RDY
TL;DR
DRL filed a 6-K, confirming 20-F filings. Standard procedure.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on August 8, 2025, indicating it files annual reports under Form 20-F. The filing is a report of a foreign private issuer pursuant to SEC rules. The company is headquartered in Hyderabad, Telangana, India.
Why It Matters
This filing confirms Dr. Reddy's Laboratories' status as a foreign private issuer and its reporting obligations with the SEC, providing transparency for investors.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain new financial or operational information that would typically increase risk.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Registrant
- August 8, 2025 (date) — Filing Date
- Hyderabad, Telangana, India (location) — Company Headquarters
- Form 6-K (document) — Filing Type
- Form 20-F (document) — Annual Report Filing
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of a foreign private issuer required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Which annual report form does Dr. Reddy's Laboratories Ltd. file?
Dr. Reddy's Laboratories Ltd. files its annual reports under cover of Form 20-F.
Where is Dr. Reddy's Laboratories Ltd. headquartered?
The company is headquartered at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
What is the filing date of this Form 6-K?
This Form 6-K was filed on August 8, 2025.
What is the SEC file number for Dr. Reddy's Laboratories Ltd.?
The SEC file number for Dr. Reddy's Laboratories Ltd. is 1-15182.
Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.4 · Accepted 2025-08-08 06:42:15
Filing Documents
- rdy0791_6k.htm (6-K) — 46KB
- rdy0791_ex99-1.htm (EX-99.1) — 41KB
- rdy0791_ex99-1img01.jpg (GRAPHIC) — 198KB
- rdy0791_ex99-1img02.jpg (GRAPHIC) — 254KB
- rdy0791_ex99-1img03.jpg (GRAPHIC) — 240KB
- rdy0791_ex99-1img04.jpg (GRAPHIC) — 267KB
- rdy0791_ex99-1img05.jpg (GRAPHIC) — 268KB
- rdy0791_ex99-1img06.jpg (GRAPHIC) — 301KB
- rdy0791_ex99-1img07.jpg (GRAPHIC) — 261KB
- rdy0791_ex99-1img08.jpg (GRAPHIC) — 281KB
- rdy0791_ex99-1img09.jpg (GRAPHIC) — 249KB
- rdy0791_ex99-1img10.jpg (GRAPHIC) — 259KB
- rdy0791_ex99-1img11.jpg (GRAPHIC) — 239KB
- rdy0791_ex99-1img12.jpg (GRAPHIC) — 176KB
- rdy0791_ex99-1img13.jpg (GRAPHIC) — 10KB
- rdy0791_ex99-1img14.jpg (GRAPHIC) — 8KB
- 0001575872-25-000520.txt ( ) — 4225KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: August 8, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3